The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C07 | Beta blocking agents | |
| 3 | C07F | Beta blocking agents and other antihypertensives | |
| 4 | C07FX | Beta blocking agents, other combinations |
| Code | Title | |
|---|---|---|
| C07FX01 | ||
| C07FX02 | ||
| C07FX03 | ||
| C07FX04 | Bisoprolol and acetylsalicylic acid | |
| C07FX05 | ||
| C07FX06 |
| Active Ingredient | Description | |
|---|---|---|
| Carvedilol and Ivabradine |
Carvedilol is a vasodilating non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha 1-receptor blockade and suppresses the renin-angiotensin system through non-selective betablockade. Ivabradine is a pure heart rate lowering agent, acting by selective and specific inhibition of the cardiac pacemaker If current that controls the spontaneous diastolic depolarisation in the sinus node and regulates heart rate. The cardiac effects are specific to the sinus node with no effect on intra-atrial, atrioventricular or intraventricular conduction times, nor on myocardial contractility or ventricular repolarisation. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CARIVALAN Film-coated tablet | Health Sciences Authority (SG) | MPI, EU: SmPC |
